Results 131 to 140 of about 16,693,716 (227)
Short-term and long-term outcomes of laparoscopic colectomy with multivisceral resection for surgical T4b colon cancer: Comparison with open colectomy. [PDF]
Miyo M +9 more
europepmc +1 more source
Inflammatory Markers and Outcomes After Liver Resection for Colorectal Liver Metastases
ABSTRACT Background and Objectives The liver is the main site of colorectal metastatic disease. This study evaluated the association of Neutrophil‐to‐Lymphocyte Ratio (NLR), Platelet‐to‐Lymphocyte Ratio (PLR), and Monocyte‐to‐Lymphocyte Ratio (MLR) among patients with colorectal liver metastases (CRLM) undergoing liver resection.
Rider May Cedro +8 more
wiley +1 more source
The Impact of Comorbid Diabetes on Short-Term Postoperative Outcomes in Stage I/II Colon Cancer Patients Undergoing Open Colectomy. [PDF]
Lee KC +6 more
europepmc +1 more source
ABSTRACT Background The pan‐immune inflammation value (PIV) and prognostic nutritional index (PNI) are established markers of systemic inflammatory/immune status and nutritional status, respectively. The potential synergistic effect of combining these indices remains unexplored. This study aimed to evaluate the utility of a novel combined PIV‐PNI score
Zihao Chen +5 more
wiley +1 more source
Association of laparoscopic colectomy versus open colectomy on the long-term health-related quality of life of colon cancer survivors. [PDF]
Thong MSY +5 more
europepmc +1 more source
ABSTRACT Background Despite an expanding repertoire of advanced therapies for inflammatory bowel disease (IBD), treatment outcomes remain suboptimal, with only 30%–40% of patients achieving sustained remission. Emerging evidence indicates that therapeutic outcomes are shaped by complex interactions between host immune pathways, the gut microbiome and ...
John P. Thomas +14 more
wiley +1 more source
An international modified Delphi study identified stakeholder consensus on population, interventions, comparators and outcomes to inform development of a future multi‐arm, multi‐stage adaptive platform trial for Crohn's disease. ABSTRACT Background and Aims The expanding range of advanced therapies for Crohn's disease (CD) has increased complexity in ...
Shellie J. Radford +15 more
wiley +1 more source
A prospective study of 150 outpatients with moderate‐to‐severe UC initiating treatment. IUS is performed at baseline, day‐2, ‐7, ‐90 and week 52 alongside clinical, biochemical, endoscopic, patient‐reported and exploratory multiomics assessments. The primary endpoint evaluates whether early change in BWT predicts treatment escalation within 3 and 12 ...
Sabrina Josefsen +6 more
wiley +1 more source
Summary Introduction The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) is recommended by peri‐operative core outcome sets as a measure of disability. Despite its growing use, the effect of different surgical procedures on disability measured by WHODAS 2.0 remains poorly understood and heterogeneous reporting across studies ...
Romijn M. Boerlage +7 more
wiley +1 more source

